Pillstats
Tablet, Film Coated

Quinapril Hydrochloride/Hydrochlorothiazide

Hydrochlorothiazide + Quinapril Hydrochloride

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US2 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCC09AA06
RxCUI (US)35208
US makers1 labelers
Packages5
DEA / ScheduleNone

Medicaid dispensing volume

No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Aurobindo Pharma Limitedunknown5SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jan 19, 2023
    SHORTAGEDrug shortage: Quinapril/Hydrochlorothiazide Tablet (Aurobindo Pharma USA)

    Quinapril/Hydrochlorothiazide Tablet — reported in shortage by Aurobindo Pharma USA. Therapeutic category: Cardiovascular.

  • Oct 5, 2022
    RECALLRecall (Class II): Quinapril and Hydrochlorothiazide Tablets, USP 20mg/12.5mg, 90 Tablets bottles Distributed by: Aurobindo Pharma USA, In…

    CGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit. — Recalling firm: Aurobindo Pharma USA Inc. — Nationwide